Kaiima Bio-Agritech
Genomic Multiplication to Boost Crop Productivity
StartupKaiima Bio-Agritech is a Sharona-based startup in the Agriculture & Food Technologies sector, established in 2006. Genomic Multiplication to Boost Crop Productivity. The company has raised a total of $92.4M across 4 funding rounds, currently at the Mature stage. Key investors include Musea Ventures, Mitsui & Co. Global Investment, Infinity Group, among 8 total investors. The company has 11-50 employees. Core technologies: Biologicals, Genes.
With $92.4M in total funding, Kaiima Bio-Agritech is a Mature-stage company operating in Agriculture & Food Technologies. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageMature
- ProductReleased
- ModelB2B
- Employees11-50
- HQSharona
- DistrictNorth District
- Last Round$65M
- Musea Ventures
- Mitsui & Co. Global Investment
- Infinity Group
8 investors total
11 articles covered by sources including www.greenprophet.com,
www.prnewswire.com,
www.croplife.com,
www.globes.co.il,
www.basf.com.
What does Kaiima Bio-Agritech do?
Kaiima Bio-Agritech is a plant genetics and breeding technology company that partners with seed companies and research institutes to develop solutions specifically suited to sustainable agriculture. Kaiima has developed a non-GMO platform called EP, which in conjunction with advanced breeding programs boosts the inherent productivity and resource-usage efficiency of high-impact food and energy crops. The technology induces genomic diversity within the plant genome followed by unique selection methodologies, providing immediate yield gains relative to traditional breeding systems. The companys business operations extend to castor breeding, marketing and sales (through its CastorMaxx platform), and high-quality vegetable-variety development through its Top Seeds subsidiary. In May 2017, Kaiima Bio-Agritech Ltd and Becks, the largest family-owned retail seed company in the United States, announced their agreement to evaluate the integration of Kaiimas non-GMO EP technology platform into Becks proprietary corn-breeding program. This new collaboration follows a recently completed three-year project that assessed the EP technologys efficacy in Becks elite corn germplasm.
How much funding has Kaiima Bio-Agritech raised?
Kaiima Bio-Agritech has raised $92.4M in total funding across 4 rounds. The company is currently at the Mature stage. Key investors include Musea Ventures, Mitsui & Co. Global Investment, Infinity Group.
What sector is Kaiima Bio-Agritech in?
Kaiima Bio-Agritech operates in Agriculture & Food Technologies, Ag Tech, Genetics & Input, Climate Tech, Food & Land Use, Sustainable Farming, with core technologies in Biologicals, Genes. Target customers: Agriculture & Food, Crops.
Where is Kaiima Bio-Agritech located?
Kaiima Bio-Agritech is based in Moshav Sharona, Israel, North District. The company also has offices abroad.